01 / Vendor Profile
MAXIM BIOMEDICAL, INC Federal Contracts and Awards
UEI YV7LJS28ERK8 · CAGE 4EJW3
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $112.64M in net contract obligations to MAXIM BIOMEDICAL, INC across 34 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
MAXIM BIOMEDICAL, INC contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$155.0K
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $2.59M | 9 | 3 | — |
| FY 2021 | $3.14M | 8 | 3 | +21.2% |
| FY 2022 | $54.59M | 7 | 3 | +1,636.5% |
| FY 2023 | $52.24M | 2 | 1 | −4.3% |
| FY 2024 | -$80.1K | 6 | 3 | −100.2% |
| FY 2025 | $0 | 1 | 1 | +100.0% |
| FY 2026 | $155.0K | 1 | 1 | — |
04 / Federal Customers
Which federal agencies buy from MAXIM BIOMEDICAL, INC?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 2100 | $55.06M | 12 | 48.9% | |
| 7505 | $52.24M | 6 | 46.4% | |
| 7529 | $5.25M | 8 | 4.7% | |
| 1700 | $155.0K | 1 | 0.1% | |
| 7523 | -$69.9K | 7 | -0.1% |
05 / Contracting Offices
Which contracting offices buy from MAXIM BIOMEDICAL, INC?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| W58P05 | DEPT OF THE ARMY | $54.64M | 3 | 48.5% | |
| 75A502 | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | $52.24M | 6 | 46.4% | |
| 75N920 | NATIONAL INSTITUTES OF HEALTH | $5.25M | 8 | 4.7% | |
| W911QY | DEPT OF THE ARMY | $422.2K | 9 | 0.4% | |
| N32398 | DEPT OF THE NAVY | $155.0K | 1 | 0.1% | |
| 75D301 | CENTERS FOR DISEASE CONTROL AND PREVENTION | -$69.9K | 7 | -0.1% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 6515 | MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $54.64M | 3 | 1 | 48.5% |
| 6650 | OPTICAL INSTRUMENTS, TEST EQUIPMENT, COMPONENTS AND ACCESSORIES | $49.54M | 5 | 1 | 44.0% |
| Q301 | MEDICAL- LABORATORY TESTING | $5.25M | 8 | 1 | 4.7% |
| 6550 | IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $3.27M | 12 | 4 | 2.9% |
| 6640 | LABORATORY EQUIPMENT AND SUPPLIES | -$66.2K | 6 | 1 | -0.1% |
08 / Competition Pattern
How was MAXIM BIOMEDICAL, INC’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for MAXIM BIOMEDICAL, INC?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| N3239826P0015 | May 15, 2026 | $155.0K | DEPT OF THE NAVY NAVAL MEDICAL RESEARCH CENTER | 325413 | 6550 |
10 / Interpreting the Profile
How should you evaluate MAXIM BIOMEDICAL, INC as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.